{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:05:14Z","timestamp":1777457114263,"version":"3.51.4"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.ygyno.2012.04.046","type":"journal-article","created":{"date-parts":[[2012,5,4]],"date-time":"2012-05-04T12:48:10Z","timestamp":1336135690000},"page":"229-235","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Prophylactic oophorectomy rates in relation to a guideline update on referral to genetic counseling"],"prefix":"10.1016","volume":"126","author":[{"given":"Gaia","family":"Pocobelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Chubak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Drescher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Resta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Urban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana S.M.","family":"Buist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2012.04.046_bb0005","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.1088759","article-title":"Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2","volume":"302","author":"King","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.ygyno.2012.04.046_bb0010","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","article-title":"Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies","volume":"72","author":"Antoniou","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ygyno.2012.04.046_bb0015","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1093\/jnci\/94.18.1365","article-title":"Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program","volume":"94","author":"Brose","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ygyno.2012.04.046_bb0025","series-title":"SEER cancer statistics review, 1975\u20132009 (vintage 2009 populations)","year":"2012"},{"key":"10.1016\/j.ygyno.2012.04.046_bb0030","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/jnci\/djn442","article-title":"Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers","volume":"101","author":"Rebbeck","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ygyno.2012.04.046_bb0035","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/jama.2010.1237","article-title":"Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality","volume":"304","author":"Domchek","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2012.04.046_bb0040","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/AOG.0b013e3181a11c64","article-title":"Ovarian conservation at the time of hysterectomy and long-term health outcomes in the nurses' health study","volume":"113","author":"Parker","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2012.04.046_bb0045","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ygyno.2010.12.326","article-title":"The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation","volume":"121","author":"Finch","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2012.04.046_bb0050","doi-asserted-by":"crossref","first-page":"362","DOI":"10.7326\/0003-4819-143-5-200509060-00012","article-title":"Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force","volume":"143","author":"Nelson","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ygyno.2012.04.046_bb0055","author":"Group Health Overview"},{"key":"10.1016\/j.ygyno.2012.04.046_bb0060","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1158\/1055-9965.EPI-03-0206","article-title":"Evaluating organized breast cancer screening implementation: the prevention of late-stage disease?","volume":"13","author":"Taplin","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ygyno.2012.04.046_bb0065","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/1097-0142(19900815)66:4<812::AID-CNCR2820660436>3.0.CO;2-1","article-title":"Revisions in the risk-based Breast Cancer Screening Program at Group Health Cooperative","volume":"66","author":"Taplin","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2012.04.046_bb0070","unstructured":"U.S. Department of Health and Human Services. National Institutes of Health. National Cancer Institute. SEER. Surveillance, Epidemiology and End Results Program. In: National Institutes of Health, editor. Bethesda, MD: National Institutes of Health; 2005."},{"key":"10.1016\/j.ygyno.2012.04.046_bb0075","doi-asserted-by":"crossref","first-page":"156","DOI":"10.6004\/jnccn.2006.0016","article-title":"Genetic\/familial high-risk assessment: breast and ovarian","volume":"4","author":"Daly","year":"2006","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.ygyno.2012.04.046_bb0080","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/00006250-200801000-00039","article-title":"Bulletin no. 89. Elective and risk-reducing salpingo-oophorectomy","volume":"111","author":"Practice","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2012.04.046_bb0085","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1097\/AOG.0b013e3181f38599","article-title":"Trends over time with commonly performed obstetric and gynecologic inpatient procedures","volume":"116","author":"Oliphant","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2012.04.046_bb0090","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1097\/AOG.0b013e3181f5ec9d","article-title":"Elective oophorectomy in the United States: trends and in-hospital complications, 1998\u20132006","volume":"116","author":"Asante","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2012.04.046_bb0095","first-page":"79","article-title":"Health insurance and discrimination concerns and BRCA1\/2 testing in a clinic population","volume":"11","author":"Peterson","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ygyno.2012.04.046_bb0100","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ajhg.2008.09.003","article-title":"Civilian and military genetics: nondiscrimination policy in a post-GINA world","volume":"83","author":"Baruch","year":"2008","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ygyno.2012.04.046_bb0105","author":"U.S. Department of Health and Human Services"},{"key":"10.1016\/j.ygyno.2012.04.046_bb0115","doi-asserted-by":"crossref","first-page":"5334","DOI":"10.1002\/cncr.26166","article-title":"Reported referral for genetic counseling or BRCA 1\/2 testing among United States physicians: a vignette-based study","volume":"117","author":"Trivers","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2012.04.046_bb0120","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1399-0004.2009.01329.x","article-title":"Risk-reducing mastectomy and salpingo-oophorectomy in unaffected BRCA mutation carriers: uptake and timing","volume":"77","author":"Skytte","year":"2010","journal-title":"Clin Genet"},{"key":"10.1016\/j.ygyno.2012.04.046_bb0125","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1158\/1055-9965.EPI-09-0171","article-title":"Uptake of risk-reducing surgery in unaffected women at high risk of breast and ovarian cancer is risk, age, and time dependent","volume":"18","author":"Evans","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825812003344?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825812003344?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:30:13Z","timestamp":1758771013000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825812003344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0090825812003344"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2012.04.046","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prophylactic oophorectomy rates in relation to a guideline update on referral to genetic counseling","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2012.04.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}